InVita Healthcare Technologies, Inc.

InVita Healthcare Technologies delivers advanced software solutions for healthcare and public safety sectors, focusing on improving blood management, organ donation processes, and forensic sample handling. Founded in 2020 and headquartered in Baltimore, US, InVita Healthcare Technologies specializes in software solutions for healthcare. The company was acquired by Novacap in November 2024, although financial terms were not disclosed. The CEO is Todd Collins, who has a history of leadership in technology-driven healthcare ventures.

InVita Healthcare Technologies specializes in providing comprehensive software solutions tailored for the healthcare and public safety sectors, particularly focusing on blood management, organ and tissue donation, and forensic sample management. Their flagship products include the iTransplant® platform, which facilitates the management of organ donations and transplant processes, and the STACS® Casework system, which enhances the efficiency of forensic sample processing. Each software solution is designed to optimize operations for hospitals, blood and plasma centers, organ procurement organizations, and forensic laboratories by streamlining workflows, improving data accuracy, and enhancing regulatory compliance. InVita’s products are deployed across various geographical markets, including North America and select international regions, serving a diverse client base that includes over 1,100 organizations involved in human biologics and public health.

InVita Healthcare Technologies generates revenue through a subscription-based model for its software products, enabling clients to access and utilize their technology on an ongoing basis. The company provides tailored solutions and services to its customers, fostering long-term partnerships with hospitals, blood banks, and other healthcare entities. Clients typically engage in contract agreements, which may include initial setup fees followed by annual or monthly subscription costs based on the scale of their operations and the specific software solutions utilized. The pricing structure is designed to reflect the complexity and breadth of the services offered, particularly for trademarked products like iTransplant® and STACS® Casework, ensuring that organizations can efficiently manage their critical healthcare operations.

InVita Healthcare Technologies plans to expand its product offerings and geographic reach following its acquisition by Novacap. The company is actively developing new software solutions that enhance operational efficiency in healthcare settings, with the aim to launch these products by 2025. In addition, InVita seeks to penetrate new international markets over the next three years, focusing on Europe and Asia. The recent acquisition funding will support these initiatives, enabling the company to invest in product development and marketing strategies to facilitate this growth.